Una nueva terapia génica para pacientes con síndrome nefrótico con mutaciones en NPHS2

by Revista Genética Médica

Un equipo de investigadores de la Universidad de Bristol, en Reino Unido, ha desarrollado una terapia génica con potencial para el tratamiento de pacientes con síndrome nefrótico con mutaciones en ...

Read more

Nace la Red Temática Nacional en Distrofia Miotónica tipo 1 (DM1) para impulsar el conocimiento de esta enfermedad y mejorar la calidad de vida de los pacientes a partir de un diagnóstico preciso

by INCLIVA

Han impulsado la creación de la Red Temática Nacional en Distrofia Miotónica tipo 1 que reúne a los principales grupos de investigación en DM1 y desarrollo de terapias basadas en oligonucleótido...

Read more

IQAC organises the first conference on infectious diseases

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

This project is aimed at understanding the bacterial communication mechanisms and developing more efficient diagnostic and therapeutic tools based on that, always bearing in mind the fight against the...

Read more

Preventing the tissue’s response to stiffness may be key to slowing the progression of breast tumors

by IBEC - Institut de Bioenginyeria de Catalunya

A study led by the Institute of Bioengineering of Catalonia demonstrates that laminin, a protein present in breast tissues, prevents the effects of stiffening, protecting cells against tumor growth. W...

Read more

The 'Choreography' between hormones and the brain key to understanding how women adapt to motherhood

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

The findings support the hypothesis that fluctuating hormones, mainly estrogens, are related to changes in the human brain structure, but what is yet to be determined is how this influences neuroplast...

Read more

They study the possible role of the herpes simplex virus 1 in Alzheimer's

by Universidad Autónoma de Madrid

It has been developed a new model of Alzheimer's disease to address the role of one of its risk factors: herpes virus. The results, published in the journal Microorganisms , determine the usefulness o...

Read more

One in three men worldwide are infected with genital human papillomavirus

by IDIBELL - Institut d’Investigació Biomèdica de Bellvitge

It has been shown that almost 1 in 3 men over the age of 15 are infected with at least one genital human papillomavirus (HPV) type, and 1 in 5 are infected with one or more of what are known as high r...

Read more

New biomarkers discovered for early diagnosis and treatment of rheumatoid arthritis

by Institut d'Investigació Sanitària Pere Virgili (IISPV)

A study led by the Disease Biomarkers and Molecular Mechanisms Research Group (DIBIOMEC) of the Institut d’Investigació Sanitària Pere Virgili (IISPV) and in collaboration with the Rheumatology Se...

Read more

La Fundación Jiménez Díaz incorpora el biomarcador Bladder Epicheck para optimizar el diagnóstico y seguimiento de los pacientes con cáncer de vejiga

by Fundación Jiménez Díaz

Utilizar este biomarcador es un importante avance en el diagnóstico y seguimiento de los pacientes con cáncer de vejiga que ayuda a disminuir intervenciones innecesarias sobre el tracto urinario y a...

Read more

Una prueba realizada en sangre podría detectar la enfermedad de Parkinson de forma temprana

by Revista Genética Médica

Investigadores de la Universidad Duke han desarrollado una prueba para detectar la enfermedad de Parkinson basada en medir los daños en el ADN mitocondrial en sangre periférica. Una vez optimizada, ...

Read more

Researchers find new mechanisms that cause blindness and open the door to new treatments

by Universitat de Barcelona

A team from the University of Barcelona has described how the lack of the CERKL gene alters the ability of retinal cells to fight oxidative stress generated by light and triggers cell death mechanisms...

Read more

3P Biopharmaceuticals continues its successful collaboration with Toleranzia AB to fight Myasthenia Gravis

by 3P Biopharmaceuticals

​3P Biopharmaceuticals and the Swedish company, Toleranzia AB, have successfully accomplished 1000 L full-scale GMP manufacturing of TOL2 drug substance destinated to be used in clinical study.

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un ensayo de microscopía dinámica del ...

by CSIC - Centro Superior de Investigaciones Científicas

La revista ‘Nature Protocols’ selecciona esta técnica como “pro...

Photos Stream